Mode of action of the antitumor compound girodazole (cas 135824-74-7) (RP 49532A, NSC 627434)

Add time:08/19/2019    Source:sciencedirect.com

girodazole (cas 135824-74-7) (RP 49532A) or 3-amino-1-[4-(2 amino-1H-imidazolyl]-propanol, 2HCl is an experimental antitumor compound which inhibits protein synthesis in cell cultures and in cell free systems. The compound has been evaluated for its capacity to inhibit specific assays of initiation, elongation and termination of protein synthesis. Girodazole inhibited the release of nascent peptides from polyribosomes in rabbit reticulocyte lysates indicating that the major effect of the compound is on the protein synthesis termination step.

We also recommend Trading Suppliers and Manufacturers of girodazole (cas 135824-74-7). Pls Click Website Link as below: cas 135824-74-7 suppliers

Prev:The Structures of Antibiotics Bound to the E Site Region of the 50 S Ribosomal Subunit of Haloarcula marismortui: 13-Deoxytedanolide and girodazole (cas 135824-74-7)
Next:Non-enzymatic diastereoselective asymmetric desymmetrization of 2-benzylserinols giving optically active 4-benzyl-4-hydroxymethyl-2-oxazolidinones: asymmetric syntheses of α-(hydroxymethyl)phenylalanine, N-Boc-α-methylphenylalanine, cericlamine and BIRT-377)